Abstract
Microbial translocation has been implicated as a contributing factor to the heightened immune activation observed during HIV-1 disease progression. When examined in a longitudinal study of HIV-1 seroconverters in Rakai, Uganda, microbial translocation was not associated with HIV-1 disease progression. However, the role of general immune activation in HIV disease progression in this population was not fully examined. Longitudinal serum samples of HIV-1 seroconverters in three HIV-1 disease progression groups [long-term nonprogressors (LTNP), standard progressors (SP), and rapid progressors (RP)] from Rakai, Uganda, were tested for levels of C-reactive protein (CRP), a marker for immune activation. CRP levels significantly increased in the SP group (P < 0.0001) but not in the RP group or the LTNP group. CRP levels during the first year post-HIV seroconversion in the RP group were significantly higher than those observed in the LTNP group (P < 0.05). For the entire population, CRP levels negatively correlated with lipopolysaccharide levels (P < 0.05) and were not associated with endotoxin antibody levels. This study suggests that in this population, increased immune activation is significantly associated with HIV-1 disease progression but not microbial translocation.
MeSH Terms
Blood Chemical Analysis
C-Reactive Protein/analysis
Disease Progression
HIV Infections/immunology,pathology,virology
HIV-1/immunology,isolation & purification
Humans
Longitudinal Studies
Uganda
Chemicals
C-Reactive Protein
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Redd Andrew D
Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Eaton Kevin P
Kong Xiangrong
Laeyendecker Oliver
Lutalo Tom
Wawer Maria J
Gray Ronald H
Serwadda David
Quinn Thomas C
Rakai Health Sciences Program
References (12)
12 references, click to expand
-
Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
Nat Med. 2006 Dec;12(12):1365-71
PMID: 17115046
-
Cytokine activation is predictive of mortality in Zambian patients with AIDS-related diarrhoea.
BMC Infect Dis. 2008 Nov 13;8:156
PMID: 19014537
-
Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients.
Nutrition. 1999 Nov-Dec;15(11-12):865-9
PMID: 10575662
-
The dynamics of CD4+ T-cell depletion in HIV disease.
Nature. 2001 Apr 19;410(6831):974-9
PMID: 11309627
-
Disrupting T-cell homeostasis: how HIV-1 infection causes disease.
AIDS Rev. 2003 Jul-Sep;5(3):172-7
PMID: 14598566
-
Immune activation is a dominant factor in the pathogenesis of African AIDS.
Immunol Today. 1995 Apr;16(4):187-91
PMID: 7734046
-
C-reactive protein is a marker for human immunodeficiency virus disease progression.
Arch Intern Med. 2006 Jan 9;166(1):64-70
PMID: 16401812
-
Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals.
AIDS. 1996 Nov;10(13):1535-42
PMID: 8931789
-
C-reactive protein: a critical update.
J Clin Invest. 2003 Jun;111(12):1805-12
PMID: 12813013
-
HIV disease: fallout from a mucosal catastrophe?
Nat Immunol. 2006 Mar;7(3):235-9
PMID: 16482171
-
C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting.
AIDS. 2007 Oct 1;21(15):2067-75
PMID: 17885297
-
Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa.
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6718-23
PMID: 19357303